(Q42987588)

12 November 2017

title

Long-term clinical and virological outcomes of chronic hepatitis C after successful interferon therapy (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

Natsuko Tsuda

1

1 reference

12 November 2017

Nobukazu Yuki

2

1 reference

12 November 2017

Kiyoshi Mochizuki

3

1 reference

12 November 2017

Takayuki Nagaoka

4

1 reference

12 November 2017

Masatoshi Yamashiro

5

1 reference

12 November 2017

Masao Omura

6

1 reference

12 November 2017

Kazumasa Hikiji

7

1 reference

12 November 2017

Michio Kato

8

1 reference

12 November 2017

publication date

1 November 2004

1 reference

Journal of Medical Virology

12 November 2017

published in

1 reference

12 November 2017

volume

74

1 reference

12 November 2017

issue

3

1 reference

12 November 2017

page(s)

406-413

1 reference

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group

12 November 2017

cites work

1 reference

Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy

21 January 2018

1 reference

Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy

21 January 2018

1 reference

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

21 January 2018

1 reference

Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JMV.20190

1 reference

12 November 2017

1 reference